US SB3216 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on January 16 2020 - 25% progression, died in committee
Action: 2020-01-16 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 16 2020 - 25% progression, died in committee
Action: 2020-01-16 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Prohibits private health insurance plans from imposing higher cost-sharing requirements on breast cancer diagnostic examinations than initial breast cancer screening examinations. Diagnostic examinations are generally required after an initial screening detects an abnormality and typically require additional mammogram images (e.g., x-rays).
Title
Access to Breast Cancer Diagnosis Act of 2020
Sponsors
Sen. Roy Blunt [R-MO] | Sen. Jeanne Shaheen [D-NH] |
History
Date | Chamber | Action |
---|---|---|
2020-01-16 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB2428 (Related) 2019-05-02 - Referred to the Subcommittee on Health.
Subjects
Cancer
Health
Health care costs and insurance
Health care coverage and access
Health care quality
Health promotion and preventive care
Medical tests and diagnostic methods
Women's health
Health
Health care costs and insurance
Health care coverage and access
Health care quality
Health promotion and preventive care
Medical tests and diagnostic methods
Women's health
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/3216/all-info |
Text | https://www.congress.gov/116/bills/s3216/BILLS-116s3216is.pdf |